Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.05 EUR | -1.23% | -4.69% | -35.79% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 63% by 2026.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.79% | 547M | - | ||
+75.69% | 12.57B | B- | ||
+7.17% | 6.66B | C- | ||
+15.10% | 5.5B | D+ | ||
-18.30% | 4.88B | B | ||
+14.96% | 4.1B | - | ||
-20.83% | 3.89B | B- | ||
-28.16% | 2.83B | C | ||
+44.54% | 2.31B | C- | ||
+1.98% | 2.07B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SIBN Stock
- 2K3 Stock
- Ratings SI-BONE, Inc.